Naturhouse Health Future Growth
Future criteria checks 1/6
Naturhouse Health's earnings are forecast to decline at 2% per annum while its annual revenue is expected to grow at 1.4% per year. EPS is expected to decline by 3.2% per annum. Return on equity is forecast to be 29.2% in 3 years.
Key information
-2.0%
Earnings growth rate
-3.2%
EPS growth rate
Specialty Retail earnings growth | 14.0% |
Revenue growth rate | 1.4% |
Future return on equity | 29.2% |
Analyst coverage | Low |
Last updated | 18 Mar 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 52 | 11 | 10 | 14 | 1 |
12/31/2025 | 51 | 11 | 9 | 14 | 1 |
12/31/2024 | 50 | 10 | 10 | 14 | 1 |
12/31/2023 | 50 | 11 | 20 | 21 | N/A |
9/30/2023 | 50 | 11 | 16 | 16 | N/A |
6/30/2023 | 51 | 10 | 11 | 11 | N/A |
3/31/2023 | 51 | 10 | 9 | 9 | N/A |
12/31/2022 | 52 | 10 | 6 | 7 | N/A |
9/30/2022 | 54 | 11 | 9 | 10 | N/A |
6/30/2022 | 56 | 12 | 12 | 12 | N/A |
3/31/2022 | 58 | 13 | N/A | N/A | N/A |
12/31/2021 | 58 | 13 | 16 | 16 | N/A |
9/30/2021 | 57 | 13 | N/A | N/A | N/A |
6/30/2021 | 59 | 14 | 21 | 21 | N/A |
3/31/2021 | 53 | 10 | N/A | N/A | N/A |
12/31/2020 | 55 | 9 | 14 | 15 | N/A |
9/30/2020 | 60 | 9 | N/A | N/A | N/A |
6/30/2020 | 64 | 9 | 9 | 10 | N/A |
3/31/2020 | 77 | 12 | N/A | N/A | N/A |
12/31/2019 | 82 | 13 | 19 | 20 | N/A |
9/30/2019 | 83 | 13 | N/A | N/A | N/A |
6/30/2019 | 83 | 13 | 17 | 18 | N/A |
3/31/2019 | 85 | 15 | N/A | N/A | N/A |
12/31/2018 | 87 | 15 | 19 | 20 | N/A |
9/30/2018 | 88 | 16 | N/A | N/A | N/A |
6/30/2018 | 91 | 17 | 18 | 19 | N/A |
3/31/2018 | 93 | 18 | N/A | N/A | N/A |
12/31/2017 | 95 | 20 | 15 | 16 | N/A |
9/30/2017 | 96 | 21 | N/A | N/A | N/A |
6/30/2017 | 98 | 22 | N/A | 15 | N/A |
3/31/2017 | 98 | 22 | N/A | N/A | N/A |
12/31/2016 | 98 | 23 | N/A | 16 | N/A |
9/30/2016 | 98 | 23 | N/A | N/A | N/A |
6/30/2016 | 98 | 23 | N/A | 23 | N/A |
3/31/2016 | 96 | 23 | N/A | N/A | N/A |
12/31/2015 | 96 | 23 | N/A | 21 | N/A |
9/30/2015 | 96 | 23 | N/A | N/A | N/A |
6/30/2015 | 96 | 23 | N/A | 22 | N/A |
3/31/2015 | 96 | 23 | N/A | N/A | N/A |
12/31/2014 | 96 | 23 | N/A | 25 | N/A |
12/31/2013 | 60 | 9 | N/A | 7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0R9G's earnings are forecast to decline over the next 3 years (-2% per year).
Earnings vs Market: 0R9G's earnings are forecast to decline over the next 3 years (-2% per year).
High Growth Earnings: 0R9G's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 0R9G's revenue (1.4% per year) is forecast to grow slower than the UK market (3.4% per year).
High Growth Revenue: 0R9G's revenue (1.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0R9G's Return on Equity is forecast to be high in 3 years time (29.2%)